JSA Advocates & Solicitors (JSA) advised JM Financial Limited, IIFL Capital Services Limited (formerly known as IIFL Securities Limited), and Kotak Mahindra Capital Company Limited in relation to the initial public offering of equity shares of CORONA Remedies Limited (“Offer”). The Offer comprised of Offer for Sale by certain shareholders of CORONA Remedies Limited including Sepia Investments Limited, Anchor Partners, Sage Investment Trust.
CORONA Remedies Limited is the India-focused branded pharmaceutical formulation company engaged in developing, manufacturing and marketing products in women’s healthcare, cardio-diabeto, pain management, urology and other therapeutic areas. The Offer received an overwhelming response from investors, with the issue being subscribed over 137.04 times.
The JSA Capital Markets Team was led by Arka Mookerjee, Lead Partner; with support from Anshu Bansal and Sagar Batra, Partners; Kairav Parikh, Principal Associate; Vatsla Varandani and Bhavini Mohan, Senior Associates; and Associates; Shreya Sharma, Ayushi Pandit, Ritu R Jaiswal & Aryaman Singh.
Anshu practices in the areas of Capital Markets (IPO, QIP, Rights Issues, Offer for Sale, Preferential allotments, buyback in listed space etc.).